Related Experiment Video
Updated: Jan 1, 2026

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
Published on: December 14, 2020
Abnormal 24-hour pH-impedance Testing Does Not Predict Reduced Quality of Life in Children With Reflux Symptoms
Lisa B Mahoney1, Paul D Mitchell2, Eliza Fishman1
1Aerodigestive Center, Division of Gastroenterology, Hepatology and Nutrition.
Insights
Objective reflux testing (pH-MII) did not predict quality of life (QOL) in children with reflux symptoms. Esophagitis, however, was linked to lower QOL, suggesting other conditions may impact children's well-being.
Area of Science:
- Pediatric Gastroenterology
- Quality of Life Research
Background:
- Gastroesophageal reflux (GER) symptoms are linked to reduced quality of life (QOL) in children.
- The association between objective reflux burden (24-hour multichannel intraluminal impedance with pH [pH-MII]) and QOL in children remains unclear.
Purpose of the Study:
- To identify predictors of QOL impairment in children undergoing esophageal reflux testing.
- To determine the relationship between objective GER measures, symptoms, and QOL outcomes.
Main Methods:
- Prospective, cross-sectional study of 82 children evaluated for suspected GERD.
- Utilized pH-MII, esophagogastroduodenoscopy (EGD), and validated QOL questionnaires (PGSQ, PedsQL, GI PedsQL).
Main Results:
- No significant difference in QOL scores between children with normal and abnormal pH-MII studies.
- No correlation found between individual pH-MII parameters and QOL scores.
- Gross esophagitis on EGD correlated with significantly worse PedsQL and GI PedsQL scores; microscopic esophagitis did not.
Conclusions:
- Abnormalities on pH-MII testing were not associated with reduced QOL in children.
- Findings suggest that conditions other than GERD may significantly impact children's QOL.
- Highlights the need to consider differential diagnoses for QOL impairment in pediatric GERD evaluations.
Objectives:
Symptoms of gastroesophageal reflux (GER) have been associated with reduced health-related quality of life (QOL) in children, though it is unclear whether reflux burden on objective diagnostic testing, such as 24-hour multichannel intraluminal impedance with pH (pH-MII) is associated with impaired QOL in children. Our aim was to identify predictors of QOL impairment based on the results of esophageal reflux testing.
Methods:
In this prospective, cross-sectional study of children undergoing pH-MII and esophagogastroduodenoscopy (EGD) for evaluation of suspected gastroesophageal reflux disease, we collected validated questionnaires (Pediatric Gastroesophageal Symptom and Quality of Life Questionnaire [PGSQ], Pediatric Quality of Life Inventory 4.0 [PedsQL] and PedsQL Gastrointestinal Symptoms Module [GI PedsQL]) to determine the relationship between objective measures of GER, patient-reported symptoms and QOL outcomes.
Results:
Of the 82 subjects, 38% of children had an abnormal pH-MII study. There were no significant differences in QOL scores on any questionnaire between patients with normal and abnormal pH-MII studies (P > 0.11). There was no correlation between individual pH-MII parameters and QOL scores. Subjects with gross esophagitis on EGD reported significantly worse QOL with lower total PedsQL (P = 0.002) and GI PedsQL (P = 0.03) scores. Microscopic esophagitis was not associated with differences in QOL scores (P > 0.32).
Conclusions:
There was no relationship between abnormalities on pH-MII testing and reduced QOL in children. These findings highlight the importance of considering other diagnoses beyond GERD as they may be significant drivers for QOL impairment.
More Related Videos
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

